Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 75 years old (inclusive)
- People whose liver scan (FibroScan®) shows a high level of fat in the liver (CAP Score ≥288 dB/m) but low levels of liver stiffness, suggesting little to no scarring (fibrosis score F0 to F1, below 8 kPa)
- People with a body mass index (BMI) between 25 and 40, and a waist circumference that meets specific thresholds set out in international liver disease guidelines (confirm with trial site for exact measurements)
- People whose weight has stayed roughly the same (within 5% up or down) over the past three months
Who may not be able to join:
- People who are unable to have an MRI scan, FibroScan®, or a DEXA bone/body composition scan for any reason
- People living with a metabolic condition that could significantly affect blood sugar or fat levels in the blood, or that might otherwise interfere with the study results (confirm with trial site)
- People with high blood pressure that is not well controlled (a top number of 160 or more, or a bottom number of 100 or more)
- People who have a history of heart disease related to narrowing or hardening of the arteries (such as a heart attack or stroke caused by plaque build-up)
- People currently taking medications that could affect the study results (confirm with trial site for specific medications)
- People who drink above the study's alcohol limits — more than 10 drinks per week for women or 15 per week for men (or more than 3 drinks on any single day for women, or 4 for men) — or people who are unwilling to keep their drinking habits the same throughout the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: André Marette, PhD, Laval University
Phone: +33 (0)6 75 32 66 59
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evolution of liver fat content
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.